Writers urge improvements to C&J bus service, seek voter support and weigh in on President Trump's first two weeks in office.

The money will pay for efforts to prevent and treat opioid addiction, or fund services that help people in recovery.

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll ...

If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for non-opioid pain treatments that could help quell the still raging opioid ...

Sen. Mike Yakawich's bill to prohibit the state from buying overdose reversal drugs from companies that settled with states ...

Billings, compares the state’s purchase of overdose reversal drugs like Narcan from companies that have contributed to the ...

Pfizer Settles Its Subsidiary’s Kickback Allegations for Nearly $60 Million - Pfizer Inc. agreed to pay over $59,746,277 to ...

Public health experts have concerns about the opioid reversal agent Opvee. But the company that makes it, Indivior, has found ...

A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to ...

A 37-year-old father who was killed when a medical jet crashed into a busy Northeast Philadelphia street has been identified ...

Last week’s settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits filed by state and local governments across the country is ...